Loading…
Trends in botanical dietary supplement use among US adults by cancer status: The National Health and Nutrition Examination Survey, 1999 to 2014
BACKGROUND Patients with cancer may use botanical dietary supplements (BDS) in an attempt to manage the side effects of chemotherapy, yet evidence about BDS use among patients with cancer is limited. The authors examined trends in BDS use among US adults according to cancer status and patient charac...
Saved in:
| Published in: | Cancer 2018-03, Vol.124 (6), p.1207-1215 |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c3933-4907187ac132209e5b3a8bdd83deeed9cb63ec11eaed5b4e07e3d08c215d76743 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c3933-4907187ac132209e5b3a8bdd83deeed9cb63ec11eaed5b4e07e3d08c215d76743 |
| container_end_page | 1215 |
| container_issue | 6 |
| container_start_page | 1207 |
| container_title | Cancer |
| container_volume | 124 |
| creator | Li, Chao Hansen, Richard A. Chou, Chiahung Calderón, Angela I. Qian, Jingjing |
| description | BACKGROUND
Patients with cancer may use botanical dietary supplements (BDS) in an attempt to manage the side effects of chemotherapy, yet evidence about BDS use among patients with cancer is limited. The authors examined trends in BDS use among US adults according to cancer status and patient characteristics.
METHODS
A serial, cross‐sectional study was conducted using data from the National Health and Nutrition Examination Survey from 1999 through 2014 (n = 43,644). Self‐reported cancer diagnosis history and any BDS use in the preceding 30 days were determined. The prevalence of BDS use was calculated in each cycle for respondents with and without cancer, both overall and by patient characteristics. Simple linear regression models were applied to test for trends in BDS use at a 2‐sided P value |
| doi_str_mv | 10.1002/cncr.31183 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1973459987</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2010856535</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3933-4907187ac132209e5b3a8bdd83deeed9cb63ec11eaed5b4e07e3d08c215d76743</originalsourceid><addsrcrecordid>eNp9kU1rFEEQhhtRzBq9-AOkwIuIE_tjenvamyzRCGEFswFvTU93xUyY6dn0h7q_wr9sbzZ68OCpqOLhoapeQp4zesIo5W9dcPFEMNaJB2TBqFYNZS1_SBaU0q6Rrfh6RJ6kdFNbxaV4TI645owJJhfk1yZi8AmGAP2cbRicHcEPmG3cQSrb7YgThgwlIdhpDt_g8gKsL2NO0O_A2eAwQso2l_QONtcIa5uHOVTLGdoxX4MNHtYlx2E_htOfdhrCHQIXJX7H3RtgWmvIM_C69lPy6MqOCZ_d12Ny-eF0szprzj9__LR6f944oYVoWk0V65R1THBONcpe2K73vhMeEb12_VKgYwwtetm3SBUKTzvHmfRqqVpxTF4dvNs43xZM2UxDcjiONuBckmFaiVZq3amKvvwHvZlLrBcmUzemnVxKISv1-kC5OKcU8cps4zDVLxpGzT4ms4_J3MVU4Rf3ytJP6P-if3KpADsAP4YRd_9RmdV69eUg_Q3v6pzS</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2010856535</pqid></control><display><type>article</type><title>Trends in botanical dietary supplement use among US adults by cancer status: The National Health and Nutrition Examination Survey, 1999 to 2014</title><source>Wiley-Blackwell Read & Publish Collection</source><source>EZB Electronic Journals Library</source><creator>Li, Chao ; Hansen, Richard A. ; Chou, Chiahung ; Calderón, Angela I. ; Qian, Jingjing</creator><creatorcontrib>Li, Chao ; Hansen, Richard A. ; Chou, Chiahung ; Calderón, Angela I. ; Qian, Jingjing</creatorcontrib><description>BACKGROUND
Patients with cancer may use botanical dietary supplements (BDS) in an attempt to manage the side effects of chemotherapy, yet evidence about BDS use among patients with cancer is limited. The authors examined trends in BDS use among US adults according to cancer status and patient characteristics.
METHODS
A serial, cross‐sectional study was conducted using data from the National Health and Nutrition Examination Survey from 1999 through 2014 (n = 43,644). Self‐reported cancer diagnosis history and any BDS use in the preceding 30 days were determined. The prevalence of BDS use was calculated in each cycle for respondents with and without cancer, both overall and by patient characteristics. Simple linear regression models were applied to test for trends in BDS use at a 2‐sided P value < .05. Multiple logistic regression models were performed to identify the patient factors associated with BDS use. The results were weighted to represent national estimates.
RESULTS
The prevalence of BDS use was greater among participants who had cancer compared with participants who did not have cancer, but trends remained stable during 1999 through 2014 for both groups. Trends in BDS use declined in patients with cancer who were older (Ptrend = .047), had a low annual family income (Ptrend = .028), and had a lower education level (Ptrend = .004). Among the respondents without cancer, trends in BDS use declined in those who were middle‐aged (Ptrend = .025), non‐Hispanic whites (Ptrend = .025), those with a lower education level (Ptrend = .011), and those who were not receiving prescription medication (Ptrend = .036). Patient age, sex, race/ethnicity, income, education, and health conditions were associated with BDS use.
CONCLUSIONS
The overall use of BDS remained stable during 1999 through 2014 for US adults with and without cancer, but it varied by individual characteristics. Cancer 2018;124:1207‐15. © 2017 American Cancer Society.
Trends in the use of botanical dietary supplements are studied among US adults according to cancer status and patient characteristics. Overall, the use of botanical dietary supplements has remained stable from 1999 to 2014 for US adults with and without cancer, but it has varied by individual characteristics.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.31183</identifier><identifier>PMID: 29211315</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Adult ; Adults ; Aged ; botanical dietary supplements ; Cancer ; cancer survivors ; Chemotherapy ; Cross-Sectional Studies ; Diet ; Dietary Supplements ; Education ; Female ; Health ; Humans ; Income ; Male ; Middle Aged ; Minority & ethnic groups ; National Health and Nutrition Examination Survey ; Neoplasms - diet therapy ; Nutrition ; Nutrition Surveys - statistics & numerical data ; Oncology ; Patients ; pharmacoepidemiology ; Plant Extracts - administration & dosage ; Regression analysis ; Regression models ; Self Report - statistics & numerical data ; Side effects ; Socioeconomic Factors ; trend ; Trends ; United States</subject><ispartof>Cancer, 2018-03, Vol.124 (6), p.1207-1215</ispartof><rights>2017 American Cancer Society</rights><rights>2017 American Cancer Society.</rights><rights>2018 American Cancer Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3933-4907187ac132209e5b3a8bdd83deeed9cb63ec11eaed5b4e07e3d08c215d76743</citedby><cites>FETCH-LOGICAL-c3933-4907187ac132209e5b3a8bdd83deeed9cb63ec11eaed5b4e07e3d08c215d76743</cites><orcidid>0000-0003-2124-3282</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29211315$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Chao</creatorcontrib><creatorcontrib>Hansen, Richard A.</creatorcontrib><creatorcontrib>Chou, Chiahung</creatorcontrib><creatorcontrib>Calderón, Angela I.</creatorcontrib><creatorcontrib>Qian, Jingjing</creatorcontrib><title>Trends in botanical dietary supplement use among US adults by cancer status: The National Health and Nutrition Examination Survey, 1999 to 2014</title><title>Cancer</title><addtitle>Cancer</addtitle><description>BACKGROUND
Patients with cancer may use botanical dietary supplements (BDS) in an attempt to manage the side effects of chemotherapy, yet evidence about BDS use among patients with cancer is limited. The authors examined trends in BDS use among US adults according to cancer status and patient characteristics.
METHODS
A serial, cross‐sectional study was conducted using data from the National Health and Nutrition Examination Survey from 1999 through 2014 (n = 43,644). Self‐reported cancer diagnosis history and any BDS use in the preceding 30 days were determined. The prevalence of BDS use was calculated in each cycle for respondents with and without cancer, both overall and by patient characteristics. Simple linear regression models were applied to test for trends in BDS use at a 2‐sided P value < .05. Multiple logistic regression models were performed to identify the patient factors associated with BDS use. The results were weighted to represent national estimates.
RESULTS
The prevalence of BDS use was greater among participants who had cancer compared with participants who did not have cancer, but trends remained stable during 1999 through 2014 for both groups. Trends in BDS use declined in patients with cancer who were older (Ptrend = .047), had a low annual family income (Ptrend = .028), and had a lower education level (Ptrend = .004). Among the respondents without cancer, trends in BDS use declined in those who were middle‐aged (Ptrend = .025), non‐Hispanic whites (Ptrend = .025), those with a lower education level (Ptrend = .011), and those who were not receiving prescription medication (Ptrend = .036). Patient age, sex, race/ethnicity, income, education, and health conditions were associated with BDS use.
CONCLUSIONS
The overall use of BDS remained stable during 1999 through 2014 for US adults with and without cancer, but it varied by individual characteristics. Cancer 2018;124:1207‐15. © 2017 American Cancer Society.
Trends in the use of botanical dietary supplements are studied among US adults according to cancer status and patient characteristics. Overall, the use of botanical dietary supplements has remained stable from 1999 to 2014 for US adults with and without cancer, but it has varied by individual characteristics.</description><subject>Adult</subject><subject>Adults</subject><subject>Aged</subject><subject>botanical dietary supplements</subject><subject>Cancer</subject><subject>cancer survivors</subject><subject>Chemotherapy</subject><subject>Cross-Sectional Studies</subject><subject>Diet</subject><subject>Dietary Supplements</subject><subject>Education</subject><subject>Female</subject><subject>Health</subject><subject>Humans</subject><subject>Income</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Minority & ethnic groups</subject><subject>National Health and Nutrition Examination Survey</subject><subject>Neoplasms - diet therapy</subject><subject>Nutrition</subject><subject>Nutrition Surveys - statistics & numerical data</subject><subject>Oncology</subject><subject>Patients</subject><subject>pharmacoepidemiology</subject><subject>Plant Extracts - administration & dosage</subject><subject>Regression analysis</subject><subject>Regression models</subject><subject>Self Report - statistics & numerical data</subject><subject>Side effects</subject><subject>Socioeconomic Factors</subject><subject>trend</subject><subject>Trends</subject><subject>United States</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kU1rFEEQhhtRzBq9-AOkwIuIE_tjenvamyzRCGEFswFvTU93xUyY6dn0h7q_wr9sbzZ68OCpqOLhoapeQp4zesIo5W9dcPFEMNaJB2TBqFYNZS1_SBaU0q6Rrfh6RJ6kdFNbxaV4TI645owJJhfk1yZi8AmGAP2cbRicHcEPmG3cQSrb7YgThgwlIdhpDt_g8gKsL2NO0O_A2eAwQso2l_QONtcIa5uHOVTLGdoxX4MNHtYlx2E_htOfdhrCHQIXJX7H3RtgWmvIM_C69lPy6MqOCZ_d12Ny-eF0szprzj9__LR6f944oYVoWk0V65R1THBONcpe2K73vhMeEb12_VKgYwwtetm3SBUKTzvHmfRqqVpxTF4dvNs43xZM2UxDcjiONuBckmFaiVZq3amKvvwHvZlLrBcmUzemnVxKISv1-kC5OKcU8cps4zDVLxpGzT4ms4_J3MVU4Rf3ytJP6P-if3KpADsAP4YRd_9RmdV69eUg_Q3v6pzS</recordid><startdate>20180315</startdate><enddate>20180315</enddate><creator>Li, Chao</creator><creator>Hansen, Richard A.</creator><creator>Chou, Chiahung</creator><creator>Calderón, Angela I.</creator><creator>Qian, Jingjing</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2124-3282</orcidid></search><sort><creationdate>20180315</creationdate><title>Trends in botanical dietary supplement use among US adults by cancer status: The National Health and Nutrition Examination Survey, 1999 to 2014</title><author>Li, Chao ; Hansen, Richard A. ; Chou, Chiahung ; Calderón, Angela I. ; Qian, Jingjing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3933-4907187ac132209e5b3a8bdd83deeed9cb63ec11eaed5b4e07e3d08c215d76743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adult</topic><topic>Adults</topic><topic>Aged</topic><topic>botanical dietary supplements</topic><topic>Cancer</topic><topic>cancer survivors</topic><topic>Chemotherapy</topic><topic>Cross-Sectional Studies</topic><topic>Diet</topic><topic>Dietary Supplements</topic><topic>Education</topic><topic>Female</topic><topic>Health</topic><topic>Humans</topic><topic>Income</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Minority & ethnic groups</topic><topic>National Health and Nutrition Examination Survey</topic><topic>Neoplasms - diet therapy</topic><topic>Nutrition</topic><topic>Nutrition Surveys - statistics & numerical data</topic><topic>Oncology</topic><topic>Patients</topic><topic>pharmacoepidemiology</topic><topic>Plant Extracts - administration & dosage</topic><topic>Regression analysis</topic><topic>Regression models</topic><topic>Self Report - statistics & numerical data</topic><topic>Side effects</topic><topic>Socioeconomic Factors</topic><topic>trend</topic><topic>Trends</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Chao</creatorcontrib><creatorcontrib>Hansen, Richard A.</creatorcontrib><creatorcontrib>Chou, Chiahung</creatorcontrib><creatorcontrib>Calderón, Angela I.</creatorcontrib><creatorcontrib>Qian, Jingjing</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Chao</au><au>Hansen, Richard A.</au><au>Chou, Chiahung</au><au>Calderón, Angela I.</au><au>Qian, Jingjing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trends in botanical dietary supplement use among US adults by cancer status: The National Health and Nutrition Examination Survey, 1999 to 2014</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>2018-03-15</date><risdate>2018</risdate><volume>124</volume><issue>6</issue><spage>1207</spage><epage>1215</epage><pages>1207-1215</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>BACKGROUND
Patients with cancer may use botanical dietary supplements (BDS) in an attempt to manage the side effects of chemotherapy, yet evidence about BDS use among patients with cancer is limited. The authors examined trends in BDS use among US adults according to cancer status and patient characteristics.
METHODS
A serial, cross‐sectional study was conducted using data from the National Health and Nutrition Examination Survey from 1999 through 2014 (n = 43,644). Self‐reported cancer diagnosis history and any BDS use in the preceding 30 days were determined. The prevalence of BDS use was calculated in each cycle for respondents with and without cancer, both overall and by patient characteristics. Simple linear regression models were applied to test for trends in BDS use at a 2‐sided P value < .05. Multiple logistic regression models were performed to identify the patient factors associated with BDS use. The results were weighted to represent national estimates.
RESULTS
The prevalence of BDS use was greater among participants who had cancer compared with participants who did not have cancer, but trends remained stable during 1999 through 2014 for both groups. Trends in BDS use declined in patients with cancer who were older (Ptrend = .047), had a low annual family income (Ptrend = .028), and had a lower education level (Ptrend = .004). Among the respondents without cancer, trends in BDS use declined in those who were middle‐aged (Ptrend = .025), non‐Hispanic whites (Ptrend = .025), those with a lower education level (Ptrend = .011), and those who were not receiving prescription medication (Ptrend = .036). Patient age, sex, race/ethnicity, income, education, and health conditions were associated with BDS use.
CONCLUSIONS
The overall use of BDS remained stable during 1999 through 2014 for US adults with and without cancer, but it varied by individual characteristics. Cancer 2018;124:1207‐15. © 2017 American Cancer Society.
Trends in the use of botanical dietary supplements are studied among US adults according to cancer status and patient characteristics. Overall, the use of botanical dietary supplements has remained stable from 1999 to 2014 for US adults with and without cancer, but it has varied by individual characteristics.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>29211315</pmid><doi>10.1002/cncr.31183</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-2124-3282</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0008-543X |
| ispartof | Cancer, 2018-03, Vol.124 (6), p.1207-1215 |
| issn | 0008-543X 1097-0142 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1973459987 |
| source | Wiley-Blackwell Read & Publish Collection; EZB Electronic Journals Library |
| subjects | Adult Adults Aged botanical dietary supplements Cancer cancer survivors Chemotherapy Cross-Sectional Studies Diet Dietary Supplements Education Female Health Humans Income Male Middle Aged Minority & ethnic groups National Health and Nutrition Examination Survey Neoplasms - diet therapy Nutrition Nutrition Surveys - statistics & numerical data Oncology Patients pharmacoepidemiology Plant Extracts - administration & dosage Regression analysis Regression models Self Report - statistics & numerical data Side effects Socioeconomic Factors trend Trends United States |
| title | Trends in botanical dietary supplement use among US adults by cancer status: The National Health and Nutrition Examination Survey, 1999 to 2014 |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T10%3A41%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trends%20in%20botanical%20dietary%20supplement%20use%20among%20US%20adults%20by%20cancer%20status:%20The%20National%20Health%20and%20Nutrition%20Examination%20Survey,%201999%20to%202014&rft.jtitle=Cancer&rft.au=Li,%20Chao&rft.date=2018-03-15&rft.volume=124&rft.issue=6&rft.spage=1207&rft.epage=1215&rft.pages=1207-1215&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/cncr.31183&rft_dat=%3Cproquest_cross%3E2010856535%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3933-4907187ac132209e5b3a8bdd83deeed9cb63ec11eaed5b4e07e3d08c215d76743%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2010856535&rft_id=info:pmid/29211315&rfr_iscdi=true |